UBS Initiates Coverage On Gentex with Neutral Rating, Announces Price Target of $34
Portfolio Pulse from Benzinga Newsdesk
UBS has initiated coverage on Gentex (NASDAQ:GNTX) with a Neutral rating and set a price target of $34.
September 04, 2024 | 2:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
UBS has initiated coverage on Gentex with a Neutral rating and a price target of $34, indicating a balanced view on the stock's potential.
The Neutral rating suggests that UBS does not foresee significant upside or downside in Gentex's stock price in the near term. The price target of $34 provides a specific valuation benchmark for investors.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100